We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Labelling and packaging (4)
- Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1033 result(s) found, displaying 1001 to 1025
-
Market actionsConsumers should stop using Clexane (enoxaparin) from the newly recalled batch due to impurity concerns. Check with your doctor or pharmacist to see if your supply is affected and return any contaminated product. If you have any concerns, consult your doctor.
-
-
Market actionsCertain batches of Clexane (enoxaparin) have been recalled because of an impurity. Stop using it, check with your healthcare provider, and return any affected product. If you have concerns, consult your doctor.
-
Safety alerts
-
Market actionsContinuing Australian reporting of bizarre and sometimes dangerous sleep related behaviours such as sleep walking and sleep driving in some users of zolpidem.
-
Safety alertsThe Therapeutic Goods Administration (TGA) continues to alert prescribing doctors, dentists, pharmacists and consumers to the uncommon but important association of the use of bisphosphonate drugs with osteonecrosis of the jaw.
-
Safety alertsPhenylpropanolamine is no longer available in Australia due to safety concerns, including the risk of haemorrhagic stroke. Consult your doctor if you have concerns.
-
Safety alertsParoxetine use in early pregnancy may increase the risk of congenital malformations, particularly heart defects, so women planning to become pregnant or in early pregnancy should consult their doctor.
-
Safety alertsSafety review of SSRI antidepressants for pregnant women due to possible infant heart defects.
-
Safety alertsSafety review of SSRI antidepressants for pregnant women due to potential heart defects in infants, especially with paroxetine.
-
Safety alertsGuidant Australia is issuing hazard alert letters to cardiologists on a fault with a limited number of their implantable pacemakers
-
Safety alertsSome Ayurvedic medicines have been found to contain toxic heavy metals. We're working on improving quality standards.
-
Safety alertsWe are advising that some polio vaccines produced between 1957 and 1963 were contaminated with SV40, a simian virus.
-
Safety alertsSSRI antidepressants under review for use in young people due to safety issues.
-
Safety alertsWe are advising that products containing Greater Celandine (Chelidonium majus) may cause liver problems. Use under healthcare supervision and consult your doctor if you have concerns.
-
Safety alertsFact sheet to inform consumers about the safe use of paracetamol
-
Safety alertsThis fact sheet has been prepared by the Therapeutic Goods Administration to inform health practitioners about the safe use of paracetamol.
-
Safety alertsBotanicLab herbal supplements contain undeclared prescription drugs and are not registered in Australia. Stop using them and consult your doctor for advice.
-
Safety alertsDo not use homoeopathic meningococcal 'vaccines' as they don't protect against the disease. Use approved vaccines and talk to your doctor if you have any questions.
-
Safety alertsKava-containing medicines are under review due to reports of liver damage, and a voluntary recall has been initiated while we assess their safety.
-
Safety alertsWe are advising that long-term use of oestrogen-only therapy may increase the risk of ovarian cancer. Consult your doctor if you have concerns.
-
Safety alertsThe Expert Committee has reviewed the safety of HRT and found increased risks of heart attacks, strokes, blood clots, and breast cancer, outweighing the benefits for long-term disease prevention
-
Safety alertsConsumers are advised to be cautious with kava-containing medicines due to potential liver damage, and should seek medical advice if they experience any symptoms.
-
Safety alertsHealth professionals are alerted to potential liver damage linked to kava-containing medicines, and are asked to review cases of unexplained hepatotoxicity.
-
Safety alertsStudy on sunscreens with potential estrogen-like effects.